5 Amendments of Catherine CHABAUD related to 2019/2816(RSP)
Amendment 10 #
Citation 9 a (new)
- having regard to Directive 2008/56/ CE on the Marine Strategic Framework,
Amendment 93 #
Paragraph 6
6. Highlights that emissions of pharmaceuticals into the environment may not only harm ecosystems and wildlife, but may also undermine the effectiveness of these same pharmaceuticals, as they can cause the emergence of antibiotic resistance;
Amendment 94 #
Paragraph 6 a (new)
6 a. Recalls that pharmaceuticals have diverse impacts on aquatic and marine ecosystems but also wildlife, including behavioural changes, fecundity reduction, size modification or development of sexual and reproductive abnormalities; calls therefore on the Commission to integrate concrete measures taking into account the cumulative effects of pharmaceutical products contamination on aquatic and marine species;
Amendment 96 #
Paragraph 7
7. Recalls that studies have shown that pharmaceutical products are especially present in water bodies, and that they are ineffectively filtered by wastewater treatment plants; highlights that contamination of freshwater and rivers basins naturally lead to contamination of the ocean on a global scale;
Amendment 243 #
Paragraph 35
35. Emphasises the need to support further research, particularly under the next multi-annual financial framework, on the direct impact on human health of exposure to pharmaceuticals and their residues in the environment and on better understanding how pharmaceuticals enter and persist in the environment, including in aquatic and marine ecosystems;